Marijuana
Cause for Caution? Top Executives Selling Tilray Stock
It might not be time to panic yet about Tilray, but there's likely a problem ahead.
Another Hemp Play to Consider: Charlotte's Web Holdings
Investors looking for another hemp play might consider Charlotte's Web Holdings, which deals in a range of CBD wellness products.
Kass: Tilray Is Promising but I Prefer This Other Stock in the Pot Space
Tilray will not be cash flow positive for another 2-3 years - that's not quick enough progress for me given its $7 billion dollar capitalization.
Tilray Has Rebased and Looks Poised to Rally Again - Consider Buying Strength
Let's check out the charts and indicators for this so-called pot play.
Chart of the Day: Vetting the Value of Cannabis Companies
Assessing Aurora and its peers, strictly on the numbers.
Peltz Is the Perfect Problem Solver for Aurora Cannabis
Peltz's addition should pacify a persistent critique of the company.
Aurora Cannabis' Is a Beast but the Stock Has Entered a Tricky Area Now
Aurora Cannabis' hiring of deal maker Nelson Peltz opens up a wealth of new possibilities for the Canadian pot company.
Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.
Nelson Peltz Could Be Key to Cannabis in Consumer Packaged Goods
Aurora's prominent partner could be cannabis' key to breaking into consumer segments.
Aurora Cannabis Builds Momentum, Enter Nelson Peltz
The plan is for Peltz to help the firm in maximizing potential markets to target.